Blinatumomab plus Reduced-dose Chemotherapy

DRUG2 trials

Sponsors

First Affiliated Hospital of Zhejiang University, Xianmin Song, MD

Conditions

Acute Lymphoid Leukemia (ALL)Precursor B-Cell Acute Lymphoblastic Leukemia

Phase 2

Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL

RecruitingNCT06742515

First Affiliated Hospital of Zhejiang UniversityPrecursor B-Cell Acute Lymphoblastic Leukemia

Start: 2024-10-17End: 2028-08-31Target: 20Updated: 2024-12-19

Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL

Not yet recruitingNCT06930105

Xianmin Song, MDAcute Lymphoid Leukemia (ALL)

Start: 2025-09-01End: 2028-05-01Target: 45Updated: 2025-08-06